Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/131252
Title: | Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis |
Author: | Sicras Mainar, Antoni Sánchez-Álvarez, Luis Navarro-Artieda, Ruth Darbà, Josep |
Keywords: | Sistemes d'administració de medicaments Colesterol Prescripció de medicaments Anàlisi econòmica Política sanitària Anàlisi cost-benefici Drug delivery devices Cholesterol Drug prescribing Economic analysis Medical policy Cost effectiveness |
Issue Date: | Dec-2018 |
Publisher: | BioMed Central |
Abstract: | High blood lipoprotein concentrations are one of the major risk factors for cardiovascular diseases. Drug therapy is the base of treatment; statins in particular. Both brand-name and generic presentations are available for statin therapy of high cholesterol levels. Factors that may influence their use in routine medical practice include, among others, patient persistence and adherence to treatment as prescribed by physicians. The aim of this retrospective analysis was to provide real-world evidence of treatment persistence and adherence and their consequences on economic and patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain. |
Note: | Reproducció del document publicat a: https://doi.org/10.1186/s12944-018-0918-y |
It is part of: | Lipids In Health And Disease, 2018, vol. 17, num. 277, p. 01-16 |
URI: | http://hdl.handle.net/2445/131252 |
Related resource: | https://doi.org/10.1186/s12944-018-0918-y |
ISSN: | 1476-511X |
Appears in Collections: | Articles publicats en revistes (Economia) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
686011.pdf | 1.32 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License